Navigation Links
Marken Announces Its New Logistics Operating System: Maestro™
Date:12/13/2011

LONDON, Dec. 13, 2011 /PRNewswire/ -- Marken announced today that it has significantly upgraded its existing operating system with centralized web-based application exclusively designed for its growing supply chain organization.  The system, known as 'Maestro' has an innovative flexible architecture which will enable extensive tracking of shipments, integrated documentation, client reporting and performance monitoring.  It is designed explicitly for ease of integration with client's systems to meet their growing requirements with temperature and time sensitive drugs to be shipped worldwide. Its interfaces and flexible structure enables each of its clients to input and track relevant data connected with a clinical trial and manage the hand-offs between shipments from site to lab and country to country.  This new operating system, when coupled with Marken's new Solo™ system for its depot operations, will allow Marken to manage the complete inbound and outbound cycle for clinical trials.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

"We are very proud to announce the new Maestro system to our clients," said Cyril Leger, Chief Operating Officer, Marken.  "We have been working on this new system for many months and have incorporated our best thinking as well as feedback from our clients.  Our customer service representatives can now work more efficiently around the clock, across all of our 24 branch locations, and track shipments more precisely than ever before."

"We at Marken are committed to continuing our journey towards perfection in supply chain management," said Wes Wheeler, CEO, Marken. "We know how important it is to be trusted with our clients' proprietary drugs, kits and samples.  Time is critical in the race for new drug treatments and we want to play our part, whatever it takes."

About Marken

Marken is the leading global clinical supply chain service provider dedicated to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection; Marken integrates depot and logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.

 


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
2. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
3. Marken Rapidly Responds to Global Supply Chain Security Measures
4. Marken Unveils New Japan Office
5. Keryx Biopharmaceuticals Announces Phase 2 Data for KRX-0401 (Perifosine) in Hodgkins Lymphoma Presented at ASH Meeting
6. Physicians Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX
7. Stereotaxis Announces Initial Shipments of the Epoch™ Platform to Customers
8. Jazz Pharmaceuticals Announces Stockholder Vote in Favor of Transaction With Azur Pharma Limted
9. Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc.
10. Nonin Medical Announces the European Launch of EQUANOX Advance™ Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference
11. SRP Announces Plan Doc Builder for TPAs and Brokers of Healthcare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
Breaking Medicine Technology:
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic ... Frederick area economy by obtaining investment capital for emerging technology companies. SCP ... that have already resulted in more than a million dollars of capital investment ...
(Date:6/24/2016)... ... ... Finally, a bruise cream that really works. Originally designed to reduce ... post-surgical treatment plans of a variety of other procedures including, but not limited to, ... bruising and causes a rapid resolution of bruising and inflammatory changes compared to no ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Dr. Seema Daulat, ... Evans Dermatology in the South Lamar location as of July 13, 2016. , Dr. ... School. As a medical student, she regularly volunteered at the Agape Clinic serving Dallas’ ...
Breaking Medicine News(10 mins):